Welcome!

News Feed Item

Tic Disorder Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 11, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Tic Disorder Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02280950/Tic-Disorder-Global-Clinical-Trials-Review-H2-2014.html

Tic Disorder Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Tic Disorder Global Clinical Trials Review, H2, 2014" provides data on the Tic Disorder clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tic Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tic Disorder. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Tic Disorder 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Tic Disorder to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Tic Disorder to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Tic Disorder 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Tic Disorder Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Otsuka Holdings Co., Ltd. 30
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 30
Tasly Pharmaceuticals, Inc. 31
Clinical Trial Overview of Tasly Pharmaceuticals, Inc. 31
Clinical Trial Overview of Top Institutes / Government 32
National Institute of Neurological Disorders and Stroke 32
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 32
National Institute of Mental Health 33
Clinical Trial Overview of National Institute of Mental Health 33
Yale University 34
Clinical Trial Overview of Yale University 34
Parkinson's Disease and Movement Disorder Center of Boca Raton 35
Clinical Trial Overview of Parkinson's Disease and Movement Disorder Center of Boca Raton 35
Shiraz University of Medical Sciences 36
Clinical Trial Overview of Shiraz University of Medical Sciences 36
University of California, Los Angeles 37
Clinical Trial Overview of University of California, Los Angeles 37
New York University School of Medicine 38
Clinical Trial Overview of New York University School of Medicine 38
National Center for Research Resources 39
Clinical Trial Overview of National Center for Research Resources 39
Massachusetts General Hospital 40
Clinical Trial Overview of Massachusetts General Hospital 40
Washington University School of Medicine 41
Clinical Trial Overview of Washington University School of Medicine 41
Five Key Clinical Profiles 42
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 69

List of Tables

Tic Disorder Therapeutics, Global, Clinical Trials by Region, 2014* 7
Tic Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Tic Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Tic Disorder Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Tic Disorder Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Tic Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Tic Disorder Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Tic Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Tic Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Tic Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Tic Disorder Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Tic Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Tic Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Tic Disorder Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Tic Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Tic Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Tic Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Tic Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Tic Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 30
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Tasly Pharmaceuticals, Inc., 2014* 31
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 32
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 33
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 34
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Parkinson's Disease and Movement Disorder Center of Boca Raton, 2014* 35
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014* 36
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 37
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014* 38
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 39
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 40
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 41

List of Figures

Tic Disorder Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Tic Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Tic Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Tic Disorder Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Tic Disorder Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Tic Disorder Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Tic Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Tic Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Tic Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Tic Disorder Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Tic Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Tic Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Tic Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Tic Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Tic Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Tic Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Tic Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 68


To order this report: Tic Disorder Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02280950/Tic-Disorder-Global-Clinical-Trials-Review-H2-2014.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
As businesses evolve, they need technology that is simple to help them succeed today and flexible enough to help them build for tomorrow. Chrome is fit for the workplace of the future — providing a secure, consistent user experience across a range of devices that can be used anywhere. In her session at 21st Cloud Expo, Vidya Nagarajan, a Senior Product Manager at Google, will take a look at various options as to how ChromeOS can be leveraged to interact with people on the devices, and formats th...
Is advanced scheduling in Kubernetes achievable? Yes, however, how do you properly accommodate every real-life scenario that a Kubernetes user might encounter? How do you leverage advanced scheduling techniques to shape and describe each scenario in easy-to-use rules and configurations? In his session at @DevOpsSummit at 21st Cloud Expo, Oleg Chunikhin, CTO at Kublr, will answer these questions and demonstrate techniques for implementing advanced scheduling. For example, using spot instances ...
First generation hyperconverged solutions have taken the data center by storm, rapidly proliferating in pockets everywhere to provide further consolidation of floor space and workloads. These first generation solutions are not without challenges, however. In his session at 21st Cloud Expo, Wes Talbert, a Principal Architect and results-driven enterprise sales leader at NetApp, will discuss how the HCI solution of tomorrow will integrate with the public cloud to deliver a quality hybrid cloud e...
SYS-CON Events announced today that Yuasa System will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Yuasa System is introducing a multi-purpose endurance testing system for flexible displays, OLED devices, flexible substrates, flat cables, and films in smartphones, wearables, automobiles, and healthcare.
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
DevOps is under attack because developers don’t want to mess with infrastructure. They will happily own their code into production, but want to use platforms instead of raw automation. That’s changing the landscape that we understand as DevOps with both architecture concepts (CloudNative) and process redefinition (SRE). Rob Hirschfeld’s recent work in Kubernetes operations has led to the conclusion that containers and related platforms have changed the way we should be thinking about DevOps and...
The session is centered around the tracing of systems on cloud using technologies like ebpf. The goal is to talk about what this technology is all about and what purpose it serves. In his session at 21st Cloud Expo, Shashank Jain, Development Architect at SAP, will touch upon concepts of observability in the cloud and also some of the challenges we have. Generally most cloud-based monitoring tools capture details at a very granular level. To troubleshoot problems this might not be good enough.
When it comes to cloud computing, the ability to turn massive amounts of compute cores on and off on demand sounds attractive to IT staff, who need to manage peaks and valleys in user activity. With cloud bursting, the majority of the data can stay on premises while tapping into compute from public cloud providers, reducing risk and minimizing need to move large files. In his session at 18th Cloud Expo, Scott Jeschonek, Director of Product Management at Avere Systems, discussed the IT and busine...
SYS-CON Events announced today that Dasher Technologies will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Dasher Technologies, Inc. ® is a premier IT solution provider that delivers expert technical resources along with trusted account executives to architect and deliver complete IT solutions and services to help our clients execute their goals, plans and objectives. Since 1999, we'v...
Enterprises have taken advantage of IoT to achieve important revenue and cost advantages. What is less apparent is how incumbent enterprises operating at scale have, following success with IoT, built analytic, operations management and software development capabilities – ranging from autonomous vehicles to manageable robotics installations. They have embraced these capabilities as if they were Silicon Valley startups. As a result, many firms employ new business models that place enormous impor...
We all know that end users experience the Internet primarily with mobile devices. From an app development perspective, we know that successfully responding to the needs of mobile customers depends on rapid DevOps – failing fast, in short, until the right solution evolves in your customers' relationship to your business. Whether you’re decomposing an SOA monolith, or developing a new application cloud natively, it’s not a question of using microservices – not doing so will be a path to eventual b...
SYS-CON Events announced today that Massive Networks, that helps your business operate seamlessly with fast, reliable, and secure internet and network solutions, has been named "Exhibitor" of SYS-CON's 21st International Cloud Expo ®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. As a premier telecommunications provider, Massive Networks is headquartered out of Louisville, Colorado. With years of experience under their belt, their team of...
SYS-CON Events announced today that Taica will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Taica manufacturers Alpha-GEL brand silicone components and materials, which maintain outstanding performance over a wide temperature range -40C to +200C. For more information, visit http://www.taica.co.jp/english/.
SYS-CON Events announced today that TidalScale, a leading provider of systems and services, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. TidalScale has been involved in shaping the computing landscape. They've designed, developed and deployed some of the most important and successful systems and services in the history of the computing industry - internet, Ethernet, operating s...
SYS-CON Events announced today that MIRAI Inc. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MIRAI Inc. are IT consultants from the public sector whose mission is to solve social issues by technology and innovation and to create a meaningful future for people.